Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other Psychoactive Substance Abuse with Psychoactive Substance-Induced Persisting Dementia
- ICD-10 Code: F19.17
Summary
This condition involves the abuse of psychoactive substances not classified in other specific categories, accompanied by a persisting dementia directly attributable to the substance use. The dementia results in cognitive impairment that persists beyond the acute effects of the substance, affecting memory, thinking, and daily functioning.
Causes
The condition arises from the chronic or repeated use of psychoactive substances, which can lead to neurotoxic effects and irreversible brain damage. The specific substances involved are not categorized under more detailed codes, but their use is linked to the development of dementia.
Risk Factors
- Prolonged or heavy use of psychoactive substances
- Advanced age (increased vulnerability to cognitive decline)
- Pre-existing cognitive impairment or neurological conditions
- Concurrent use of multiple substances
- Poor nutrition or overall health status
Symptoms
- Significant memory loss or confusion
- Impaired judgment or problem-solving abilities
- Difficulty with language or communication
- Changes in personality or behavior
- Reduced ability to perform daily activities independently
Diagnosis
Diagnosis requires a clinical assessment by a healthcare professional, including a detailed history of substance use and cognitive testing. Neuroimaging or neuropsychological evaluations may be used to confirm dementia and rule out other causes. Substance screening may support the evaluation of ongoing or past use.
Treatment Options
- Discontinuation of the psychoactive substance to prevent further cognitive decline
- Cognitive rehabilitation therapies to improve functioning
- Management of co-occurring mental health conditions
- Supportive care to address daily living needs
- Monitoring for other substance-related complications
Prognosis and Follow-Up
The prognosis depends on the extent of cognitive damage and the ability to maintain abstinence from substances. Regular follow-up is essential to monitor cognitive status, manage symptoms, and adjust care plans as needed. Early intervention may help slow progression but cannot reverse existing damage.
Complications
- Progressive cognitive decline
- Increased risk of accidents or injuries due to impaired judgment
- Social isolation or dependency on others for care
- Higher likelihood of other substance-related health issues
Lifestyle & Prevention
- Avoiding all psychoactive substances to prevent further harm
- Engaging in mentally stimulating activities to support cognitive function
- Maintaining a healthy diet and regular exercise
- Seeking support for substance use to reduce relapse risk
- Using safety measures (e.g., home modifications) to prevent accidents
When to Seek Professional Help
Seek immediate medical attention if experiencing sudden worsening of confusion, memory loss, or behavioral changes. Consult a healthcare provider for ongoing substance use or if cognitive symptoms interfere with daily life.
Tips for Medical Coders
Document the specific psychoactive substance involved, if known, and confirm the presence of substance-induced persisting dementia through clinical evaluation. Ensure the diagnosis aligns with the criteria for F19.17, including the direct link between substance use and dementia.
Medical Policies and Guidelines
Related policies from health plans
F19.17 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.